building innovation capabilities at nhrd

12
Honing innovation capabilities: Leadership and Culture Pavan Soni Innovation Evangelist and Researcher [email protected] www.pavansoni.com

Upload: pavan-soni

Post on 15-Apr-2017

584 views

Category:

Business


5 download

TRANSCRIPT

Page 1: Building Innovation Capabilities at NHRD

Honing innovation capabilities: Leadership

and Culture

Pavan SoniInnovation Evangelist and

Researcher [email protected]

www.pavansoni.com

Page 2: Building Innovation Capabilities at NHRD

What are capabilities?

Repeatability | Reliability | Embedded | Purposeful | Coordinated

Page 3: Building Innovation Capabilities at NHRD

How capabilities come into being

05/03/2023 Pavan Soni, Innovation Evangelist 3

Products Services Processes Customers …

Processes People Culture

Leadership Founder/ Entrepreneur

Business Model Institutions

Formal | Informal

Environment Munificence | Dynamism | Complexity

Page 4: Building Innovation Capabilities at NHRD

Creating a stretch “Developing capital-intensive premium products through disruptively innovative process engineering that could deliver affordable pricing and make a difference to global healthcare.”

- Kiran Mazumdar-Shaw, Founder and CMD, Biocon Ltd.

1978- Enzymes (solid substrate fermentation)

1996- Statins using

fermentation

2007- Enters Biosimilars

Exits enzymes biz.

2003- Insulin (Pichia expression system)

2004- INSUGEN®(rh-insulin)2006- BIOMAb-EGFR™(Nimotuzumab), India’s first anti-cancer drug 2009- BASALOG®(Glargine) 2013- ALZUMAb™(Itolizumab), a 'first in class' anti-CD6 monoclonal antibody2014- CANMAb™ (Trastuzumab)

05/03/2023 Pavan Soni, Innovation Evangelist 4

2006- Launches Biocon

Biopharmaceuticals

2009- Tie-up with Mylan for

Biosimilars

World-leading research on Oral Insulin

Leadership

Page 5: Building Innovation Capabilities at NHRD

Sensing and shaping opportunities

05/03/2023 Pavan Soni, Innovation Evangelist 5

“To be a discovery-led global pharmaceutical company.”

- Anji K Reddy, Founder, Dr. Reddy’s Lab

1984- DRL develops APIs (Methyldopa)

1980-84- Uniloids, Standard Organics

1986- Formulations, Enters US market

1991- First to enter Russia and Soviet block

1993- First to set-up discovery research

1996- Forms biotechnology division

1997- First to co-license to Novo Nordisk

2001- Enters US generics

2008- Sets up Speciality Pharma/ Complex

Generics

Discovery- centricity

Patient- centricityCost- centricity

Leadership

Page 6: Building Innovation Capabilities at NHRD

State of perpetual crisis

05/03/2023 Pavan Soni, Innovation Evangelist 6

“We want to beat Sony by 2005!”- Eric Kim, Head of Marketing, Samsung (2001)

“Change everything, except your wife and kids.”- Lee Kun-hee, Chairman, Samsung

Public burning of over 100,000 cordless phones at Samsung Gumi factory on March 9, 1995 

Paradoxes that drive Samsung: Size and speed Diversified but specialized Japanese and American management styles combined

Innovation through Bold investments Being the fast

follower Co-opetition Owner-led

transformation

Leadership

Page 7: Building Innovation Capabilities at NHRD

As a leader

05/03/2023 Pavan Soni, Innovation Evangelist 7

Leadership

Creating a stretch Setting impossible goals Maintaining a state of

perpetual crisis Sensing and shaping

opportunities

Page 8: Building Innovation Capabilities at NHRD

Variation and selection

05/03/2023 Pavan Soni, Innovation Evangelist 8

Great Ideas are born at the Intersection of Disciplines- Frans Johansson

Discovering Intersections

Operating Engineer Model (1994) Diploma holders 25% built-in attrition 80+% of shop floor- 50+ plants Systemic innovation

Leadership embraces failure Operational autonomy Non pharma scientists in IPDOSelf Managed Teams (2001)

Culture

Page 9: Building Innovation Capabilities at NHRD

Operational autonomy and financial accountability

05/03/2023 Pavan Soni, Innovation Evangelist 9

Culture

“We believe that any significant growth requires investment, and, very often, the growth that we see is linked to the level of investment that we make. A challenge, though a tough one, is to manage the conflict of investing in building the future without diluting the current results.”

- Azim H Premji, Chairman of Wipro Ltd.

Stage Gate Model of R&D funding (2001)

Quantum Innovations (2006)

Technology Themes (2008)

Centers of Excellence (1996)

Practice Framework (2002)

Point Solutions (2003)

Let a million flowers blossom

Page 10: Building Innovation Capabilities at NHRD

Enabling improvisation

05/03/2023 Pavan Soni, Innovation Evangelist 10

Culture

Page 11: Building Innovation Capabilities at NHRD

On the culture

05/03/2023 Pavan Soni, Innovation Evangelist 11

Culture

Introducing variation and selection

Operational autonomy and financial accountability

An innovation anchor Focus on innovation culture,

not outcome Enabling improvisation

Page 12: Building Innovation Capabilities at NHRD

In summary

05/03/2023 Pavan Soni, Innovation Evangelist 12

Introducing variation and selection

Operational autonomy and financial accountability

An innovation anchor Focus on innovation

culture, not outcome Enabling improvisation

Culture Leadership

Creating a stretch Setting impossible

goals Maintaining a state of

perpetual crisis Sensing and shaping

opportunities